查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1349440

手掌多汗症治療市場 - 全球產業分析、規模、佔有率、成長、趨勢和預測，2023-2031 年

Palmar Hyperhidrosis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 130 Pages | 商品交期: 2-10個工作天內

價格

手掌多汗症治療市場 - 報告範圍

TMR 關於全球手汗症治療市場的報告研究了過去以及當前的成長趨勢和機會，以獲得 2023 年至 2031 年預測期內市場指標的寶貴見解。該報告提供了全球手汗症治療的收入2017- 2031年期間的市場，考慮2023年為基準年，2031年為預測年。報告中也提供了2023年至2031年全球手汗症治療市場的年複合成長率（CAGR%）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解手汗症治療市場。

市場概況
2023年市場價值 3.181 億美元
2031 年市場價值 4.232 億美元
年複合成長率 0.033%

該報告深入研究了全球手汗症治療市場的競爭格局。已經確定了全球手掌多汗症治療市場的主要參與者，並對其中每位參與者的各種屬性進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告中介紹的全球手汗症治療市場參與者的屬性。

目錄

第一章：前言

第 2 章：假設與研究方法

第 3 章：執行摘要：全球市場

第 4 章：市場概覽

  • 介紹
  • 概述
  • 市場動態
  • 2017-2031年全球市場分析與預測
  • 波特五力分析

第 5 章：關鍵見解

  • 手掌多汗症：全球主要國家的疾病盛行率
  • 概述：治療方案的進步
  • 監管場景
  • COVID-19 大流行對該行業的影響

第 6 章：全球市場分析與預測：依治療類型

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：依治療類型，2017-2031
    • Botox（肉毒桿菌）
    • 藥物治療
    • 離子電滲透療法
    • 內視鏡胸腔交感神經切除術 (ETS) 手術
  • 市場吸引力分析：按治療類型

第 7 章：全球市場分析與預測：按最終用戶

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：按最終用戶，2017-2031
    • 醫院
    • 皮膚科診所
    • 美容中心
    • 其他（家庭護理設置等）
  • 市場吸引力分析：按最終用戶

第 8 章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：按地區

第 9 章：北美市場分析與預測

第 10 章：歐洲市場分析與預測

第 11 章：亞太市場分析與預測

第 12 章：拉丁美洲市場分析與預測

第 13 章：中東和非洲市場分析與預測

第 14 章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 市佔率分析：依公司分類，2022 年
  • 公司簡介
    • AbbVie, Inc.
    • Eli Lilly and Company
    • TheraVida, Inc.
    • Person & Covey, Inc.
    • Hugel, Inc.
    • Dr. Reddy's Laboratories Ltd.
    • Avanor Healthcare Ltd
    • Fresh Tracks Therapeutics, Inc.
    • Kaken Pharmaceutical Co., Ltd.
Product Code: TMRGL62196

Palmar Hyperhidrosis Treatment Market - Scope of Report

TMR's report on the global palmar hyperhidrosis treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global palmar hyperhidrosis treatment market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global palmar hyperhidrosis treatment market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the palmar hyperhidrosis treatment market.

Market Snapshot
Market Value in 2023US$ 318.1 Mn
Market Value in 2031US$ 423.2 Mn
CAGR3.3%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global palmar hyperhidrosis treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global palmar hyperhidrosis treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global palmar hyperhidrosis treatment market.

The report delves into the competitive landscape of the global palmar hyperhidrosis treatment market. Key players operating in the global palmar hyperhidrosis treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global palmar hyperhidrosis treatment market profiled in this report.

Key Questions Answered in Global Palmar Hyperhidrosis Treatment Market Report:

  • What is the sales/revenue generated by palmar hyperhidrosis treatment across all regions during the forecast period?
  • What are the opportunities in the global palmar hyperhidrosis treatment market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Palmar Hyperhidrosis Treatment Market - Research Objectives and Research Approach

The comprehensive report on the global palmar hyperhidrosis treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global palmar hyperhidrosis treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global palmar hyperhidrosis treatment market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Palmar Hyperhidrosis Treatment Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Palmar Hyperhidrosis Treatment Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)
  • 4.5. Porter's Five Force Analysis

5. Key Insights

  • 5.1. Palmar Hyperhidrosis: Disease Prevalence Rate globally with key countries
  • 5.2. Overview: Advancements in Treatment Options
  • 5.3. Regulatory Scenario
  • 5.4. COVID-19 Pandemics Impact on Industry

6. Global Palmar Hyperhidrosis Treatment Market Analysis and Forecast, by Treatment Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Treatment Type, 2017-2031
    • 6.3.1. Botox (Botulinum Toxin)
    • 6.3.2. Medical Therapy
    • 6.3.3. Iontophoresis
    • 6.3.4. Endoscopic Thoracic Sympathectomy (ETS) Surgery
  • 6.4. Market Attractiveness Analysis, by Treatment Type

7. Global Palmar Hyperhidrosis Treatment Market Analysis and Forecast, by End-user

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by End-user, 2017-2031
    • 7.3.1. Hospitals
    • 7.3.2. Dermatology Clinics
    • 7.3.3. Aesthetic Centers
    • 7.3.4. Others (Homecare Settings, etc.)
  • 7.4. Market Attractiveness Analysis, by End-user

8. Global Palmar Hyperhidrosis Treatment Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast, by Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness Analysis, by Region

9. North America Palmar Hyperhidrosis Treatment Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast, by Treatment Type, 2017-2031
    • 9.2.1. Botox (Botulinum Toxin)
    • 9.2.2. Medical Therapy
    • 9.2.3. Iontophoresis
    • 9.2.4. Endoscopic Thoracic Sympathectomy (ETS) Surgery
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Hospitals
    • 9.3.2. Dermatology Clinics
    • 9.3.3. Aesthetic Centers
    • 9.3.4. Others (Homecare Settings, etc.)
  • 9.4. Market Value Forecast, by Country, 2017-2031
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Treatment Type
    • 9.5.2. By End-user
    • 9.5.3. By Country

10. Europe Palmar Hyperhidrosis Treatment Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Treatment Type, 2017-2031
    • 10.2.1. Botox (Botulinum Toxin)
    • 10.2.2. Medical Therapy
    • 10.2.3. Iontophoresis
    • 10.2.4. Endoscopic Thoracic Sympathectomy (ETS) Surgery
  • 10.3. Market Value Forecast, by End-user, 2017-2031
    • 10.3.1. Hospitals
    • 10.3.2. Dermatology Clinics
    • 10.3.3. Aesthetic Centers
    • 10.3.4. Others (Homecare Settings, etc.)
  • 10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Spain
    • 10.4.5. Italy
    • 10.4.6. Rest of Europe
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Treatment Type
    • 10.5.2. By End-user
    • 10.5.3. By Country/Sub-region

11. Asia Pacific Palmar Hyperhidrosis Treatment Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Treatment Type, 2017-2031
    • 11.2.1. Botox (Botulinum Toxin)
    • 11.2.2. Medical Therapy
    • 11.2.3. Iontophoresis
    • 11.2.4. Endoscopic Thoracic Sympathectomy (ETS) Surgery
  • 11.3. Market Value Forecast, by End-user, 2017-2031
    • 11.3.1. Hospitals
    • 11.3.2. Dermatology Clinics
    • 11.3.3. Aesthetic Centers
    • 11.3.4. Others (Homecare Settings, etc.)
  • 11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.4.1. China
    • 11.4.2. Japan
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Treatment Type
    • 11.5.2. By End-user
    • 11.5.3. By Country/Sub-region

12. Latin America Palmar Hyperhidrosis Treatment Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Treatment Type, 2017-2031
    • 12.2.1. Botox (Botulinum Toxin)
    • 12.2.2. Medical Therapy
    • 12.2.3. Iontophoresis
    • 12.2.4. Endoscopic Thoracic Sympathectomy (ETS) Surgery
  • 12.3. Market Value Forecast, by End-user, 2017-2031
    • 12.3.1. Hospitals
    • 12.3.2. Dermatology Clinics
    • 12.3.3. Aesthetic Centers
    • 12.3.4. Others (Homecare Settings, etc.)
  • 12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Treatment Type
    • 12.5.2. By End-user
    • 12.5.3. By Country/Sub-region

13. Middle East & Africa Palmar Hyperhidrosis Treatment Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Treatment Type, 2017-2031
    • 13.2.1. Botox (Botulinum Toxin)
    • 13.2.2. Medical Therapy
    • 13.2.3. Iontophoresis
    • 13.2.4. Endoscopic Thoracic Sympathectomy (ETS) Surgery
  • 13.3. Market Value Forecast, by End-user, 2017-2031
    • 13.3.1. Hospitals
    • 13.3.2. Dermatology Clinics
    • 13.3.3. Aesthetic Centers
    • 13.3.4. Others (Homecare Settings, etc.)
  • 13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Treatment Type
    • 13.5.2. By End-user
    • 13.5.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (by tier and size of companies)
  • 14.2. Market Share Analysis, by Company, 2022
  • 14.3. Company Profiles
    • 14.3.1. AbbVie, Inc.
      • 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.1.2. Product Portfolio
      • 14.3.1.3. Financial Overview
      • 14.3.1.4. SWOT Analysis
      • 14.3.1.5. Strategic Overview
    • 14.3.2. Eli Lilly and Company
      • 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.2.2. Product Portfolio
      • 14.3.2.3. Financial Overview
      • 14.3.2.4. SWOT Analysis
      • 14.3.2.5. Strategic Overview
    • 14.3.3. TheraVida, Inc.
      • 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.3.2. Product Portfolio
      • 14.3.3.3. Financial Overview
      • 14.3.3.4. SWOT Analysis
      • 14.3.3.5. Strategic Overview
    • 14.3.4. Person & Covey, Inc.
      • 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.4.2. Product Portfolio
      • 14.3.4.3. Financial Overview
      • 14.3.4.4. SWOT Analysis
      • 14.3.4.5. Strategic Overview
    • 14.3.5. Hugel, Inc.
      • 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.5.2. Product Portfolio
      • 14.3.5.3. Financial Overview
      • 14.3.5.4. SWOT Analysis
      • 14.3.5.5. Strategic Overview
    • 14.3.6. Dr. Reddy's Laboratories Ltd.
      • 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.6.2. Product Portfolio
      • 14.3.6.3. Financial Overview
      • 14.3.6.4. SWOT Analysis
      • 14.3.6.5. Strategic Overview
    • 14.3.7. Avanor Healthcare Ltd
      • 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.7.2. Product Portfolio
      • 14.3.7.3. Financial Overview
      • 14.3.7.4. SWOT Analysis
      • 14.3.7.5. Strategic Overview
    • 14.3.8. Fresh Tracks Therapeutics, Inc.
      • 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.8.2. Product Portfolio
      • 14.3.8.3. Financial Overview
      • 14.3.8.4. SWOT Analysis
      • 14.3.8.5. Strategic Overview
    • 14.3.9. Kaken Pharmaceutical Co., Ltd.
      • 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.9.2. Product Portfolio
      • 14.3.9.3. Financial Overview
      • 14.3.9.4. SWOT Analysis
      • 14.3.9.5. Strategic Overview

List of Tables

  • Table 01: Global Palmar Hyperhidrosis Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017-2031
  • Table 02: Global Palmar Hyperhidrosis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 03: Global Palmar Hyperhidrosis Treatment Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 04: North America Palmar Hyperhidrosis Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017-2031
  • Table 05: North America Palmar Hyperhidrosis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 06: North America Palmar Hyperhidrosis Treatment Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 07: Europe Palmar Hyperhidrosis Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017-2031
  • Table 08: Europe Palmar Hyperhidrosis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 09: Europe Palmar Hyperhidrosis Treatment Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 10: Asia Pacific Palmar Hyperhidrosis Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017-2031
  • Table 11: Asia Pacific Palmar Hyperhidrosis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 12: Asia Pacific Palmar Hyperhidrosis Treatment Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 13: Latin America Palmar Hyperhidrosis Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017-2031
  • Table 14: Latin America Palmar Hyperhidrosis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 15: Latin America Palmar Hyperhidrosis Treatment Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 16: Middle East & Africa Palmar Hyperhidrosis Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017-2031
  • Table 17: Middle East & Africa Palmar Hyperhidrosis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 18: Middle East & Africa Palmar Hyperhidrosis Treatment Market Value (US$ Mn) Forecast, by Region, 2017-2031

List of Figures

  • Figure 01: Global Palmar Hyperhidrosis Treatment Market Value Share Analysis, by Treatment Type, 2022 and 2031
  • Figure 02: Global Palmar Hyperhidrosis Treatment Market Attractiveness Analysis, by Treatment Type, 2023-2031
  • Figure 03: Global Palmar Hyperhidrosis Treatment Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 04: Global Palmar Hyperhidrosis Treatment Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 05: Global Palmar Hyperhidrosis Treatment Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 06: Global Palmar Hyperhidrosis Treatment Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 07: North America Palmar Hyperhidrosis Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 08: North America Palmar Hyperhidrosis Treatment Market Value Share Analysis, by Treatment Type, 2022 and 2031
  • Figure 09: North America Palmar Hyperhidrosis Treatment Market Attractiveness Analysis, by Treatment Type, 2023-2031
  • Figure 10: North America Palmar Hyperhidrosis Treatment Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 11: North America Palmar Hyperhidrosis Treatment Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 12: North America Palmar Hyperhidrosis Treatment Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 13: North America Palmar Hyperhidrosis Treatment Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 14: Europe Palmar Hyperhidrosis Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 15: Europe Palmar Hyperhidrosis Treatment Market Value Share Analysis, by Treatment Type, 2022 and 2031
  • Figure 16: Europe Palmar Hyperhidrosis Treatment Market Attractiveness Analysis, by Treatment Type, 2023-2031
  • Figure 17: Europe Palmar Hyperhidrosis Treatment Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 18: Europe Palmar Hyperhidrosis Treatment Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 19: Europe Palmar Hyperhidrosis Treatment Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 20: Europe Palmar Hyperhidrosis Treatment Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 21: Asia Pacific Palmar Hyperhidrosis Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 22: Asia Pacific Palmar Hyperhidrosis Treatment Market Value Share Analysis, by Treatment Type, 2022 and 2031
  • Figure 23: Asia Pacific Palmar Hyperhidrosis Treatment Market Attractiveness Analysis, by Treatment Type, 2023-2031
  • Figure 24: Asia Pacific Palmar Hyperhidrosis Treatment Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 25: Asia Pacific Palmar Hyperhidrosis Treatment Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 26: Asia Pacific Palmar Hyperhidrosis Treatment Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 27: Asia Pacific Palmar Hyperhidrosis Treatment Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 28: Latin America Palmar Hyperhidrosis Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 29: Latin America Palmar Hyperhidrosis Treatment Market Value Share Analysis, by Treatment Type, 2022 and 2031
  • Figure 30: Latin America Palmar Hyperhidrosis Treatment Market Attractiveness Analysis, by Treatment Type, 2023-2031
  • Figure 31: Latin America Palmar Hyperhidrosis Treatment Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 32: Latin America Palmar Hyperhidrosis Treatment Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 33: Latin America Palmar Hyperhidrosis Treatment Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 34: Latin America Palmar Hyperhidrosis Treatment Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 35: Middle East & Africa Palmar Hyperhidrosis Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 36: Middle East & Africa Palmar Hyperhidrosis Treatment Market Value Share Analysis, by Treatment Type, 2022 and 2031
  • Figure 37: Middle East & Africa Palmar Hyperhidrosis Treatment Market Attractiveness Analysis, by Treatment Type, 2023-2031
  • Figure 38: Middle East & Africa Palmar Hyperhidrosis Treatment Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 39: Middle East & Africa Palmar Hyperhidrosis Treatment Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 40: Middle East & Africa Palmar Hyperhidrosis Treatment Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 41: Middle East & Africa Palmar Hyperhidrosis Treatment Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 42: Palmar Hyperhidrosis Treatment Market Share Analysis, by Company, 2022